Normal Volunteers | Liver diseases Absent | Liver function tests normal | albumin/protein.total | Lactate dehydrogenase measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Gamma glutamyl transferase measurement | Serum total bilirubin measurement | Bilirubin, direct measurement | Indirect Bilirubin Measurement | screening questionnaire | Hematologic Tests
Item
group a: normal volunteers without any history of liver disease and with normal liver functions test (lft), including total protein/albumin, ldh, alt, ast, ggt, total bilirubin, direct and indirect bilirubin and do not belong to group b. volunteers will be screened using questionnaires. those deemed suitable will then be asked to have the blood test done. all blood tests are done free of charge to subjects.
boolean
C3661466 (UMLS CUI [1])
C0023895 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0438235 (UMLS CUI [3])
C0805031 (UMLS CUI [4])
C0202113 (UMLS CUI [5])
C0201836 (UMLS CUI [6])
C0201899 (UMLS CUI [7])
C0202035 (UMLS CUI [8])
C1278039 (UMLS CUI [9])
C0201916 (UMLS CUI [10])
C1881193 (UMLS CUI [11])
C1134635 (UMLS CUI [12])
C0018941 (UMLS CUI [13])
Hepatitis B carrier | Hepatitis C carrier | Liver function
Item
group b: hepatitis b or c carriers with normal liver functions.
boolean
C0262505 (UMLS CUI [1])
C0400920 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Hepatitis B carrier | Hepatitis C carrier | Liver Dysfunction
Item
group c: hepatitis b or c carriers with abnormal liver functions.
boolean
C0262505 (UMLS CUI [1])
C0400920 (UMLS CUI [2])
C0086565 (UMLS CUI [3])
Liver Cirrhosis Biopsy of liver | Liver Cirrhosis Evidence of | Varices X-Ray Computed Tomography | Indication of Portal Hypertension
Item
group d: liver cirrhosis, proven by liver biopsy or on clinical evidences, such as varices on ct scan indicative of portal hypertension.
boolean
C0023890 (UMLS CUI [1,1])
C0193388 (UMLS CUI [1,2])
C0023890 (UMLS CUI [2,1])
C0332120 (UMLS CUI [2,2])
C0042345 (UMLS CUI [3,1])
C0040405 (UMLS CUI [3,2])
C0392360 (UMLS CUI [4,1])
C0020541 (UMLS CUI [4,2])
Liver carcinoma | Excision
Item
group e: hcc patients with resection.
boolean
C2239176 (UMLS CUI [1])
C0728940 (UMLS CUI [2])
Liver carcinoma unresectable | Therapeutic procedure
Item
group f: unresectable hcc patients with treatment.
boolean
C2239176 (UMLS CUI [1,1])
C1519810 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2])
Liver carcinoma | Malignant Neoplasm | Palliative Care
Item
group g: hcc patients with active malignant disease and only palliative care are offered.
boolean
C2239176 (UMLS CUI [1])
C0006826 (UMLS CUI [2])
C0030231 (UMLS CUI [3])
Informed Consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
Liver carcinoma | Hepatitis B carrier | Hepatitis C carrier | Space occupying lesion of liver | Alpha one fetoprotein measurement | Biopsy
Item
in this trial, diagnosis of hcc is established with either (a) known hepatitis b or c carrier, and space occupying lesion(s) in the liver and afp > 400ng/ml or (b) cytological or histological confirmation by biopsy
boolean
C2239176 (UMLS CUI [1])
C0262505 (UMLS CUI [2])
C0400920 (UMLS CUI [3])
C0579131 (UMLS CUI [4])
C0201539 (UMLS CUI [5])
C0005558 (UMLS CUI [6])
Unspecified
Item
there is no exclusion criteria
boolean
C0205370 (UMLS CUI [1])